The YouTuber highlights Co-Diagnostics for its unique molecular diagnostics platform, which benefited from COVID-19 PCR tests and has strong potential in genetic testing. The company showed explosive sales growth (34,000% last fiscal year) and maintains a robust balance sheet with over $60 million in cash and no debt, making it a potential acquisition target. The diagnostics industry is growing, and the company is well-positioned in the genetic testing space. Analysts have an average price target of $23.
“The company offers a unique platform for development of molecular diagnostics tests and and those designed for detection of dna and rna sequencing.”